Related Experiment Video
Updated: Jun 17, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Janus kinase 2: an epigenetic 'writer' that activates leukemogenic genes
1Department of Biochemistry and Biophysics, Lineberger Comprehensive Cancer Center, Howard Hughes Medical Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7295, USA.
Abstract:
Activation of Janus kinase 2 (JAK2) plays a critical role in normal hematopoiesis and leukemogenesis. Dawson et al. (2009; JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin. Nature 461, 819-822) report that JAK2 performs this function by displacing the heterochromatin protein HP1α from chromatin through phosphorylation of histone H3.
Related Concept Videos
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
Induced Pluripotent Stem Cells
Somatic cells are...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation

